Dr. Lorenza Saldivar is a Rochester, Minnesota based nurse practitioner. Active license number of Dr. Lorenza Saldivar is 22188 in Wisconsin. Her current practice location is 200 1st St Sw, Rochester. Patients can reach her at 507-284-2511. Dr. Lorenza Saldivar is DNP, APRN, FNP-C and her NPI number (Unique professional ID assigned by NPPES) is 1912666579. Dr. Lorenza Saldivar has completed additional training beyond basic nursing education and provides primary health care services in accordance with state nurse practice laws or statutes. NPs are trained to assess patient needs, order and interpret diagnostic and laboratory tests, diagnose disease, formulate and prescribe medications and treatment plans.
Complete Profile:
Dr. Lorenza Saldivar speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1912666579
NPI Enumeration Date:
10 Dec, 2021
NPI Last Update On:
22 Apr, 2022
Medical Licenses:
NPs can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Lorenza Saldivar are as mentioned below.
License Number
Specialization
State
Status
22188
Wisconsin
Primary
8834
Nurse Practitioner
Minnesota
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Dr. Lorenza Saldivar 200 1st St Sw, Rochester, Minnesota
Zip:
55905-0002
Patients can reach Dr. Lorenza Saldivar at 200 1st St Sw, Rochester, Minnesota or can call to book an appointment on 507-284-2511.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 14 October, 2024.